GLOBAL WEARABLE DEFIBRILLATOR MARKET

INTRODUCTION

 A portable medical device called a wearable defibrillator, also referred to as a wearable cardioverter-defibrillator (WCD), is intended to continuously monitor a person's heart rhythm and administer a life-saving shock if a dangerous arrhythmia, such as ventricular fibrillation or ventricular tachycardia, is detected.

WCDs are non-invasive and can be worn externally, in contrast to implantable cardioverter-defibrillators (ICDs), which are surgically installed in the chest. To continuously track the wearer's heart's electrical activity, the gadget is fitted with electrodes that come into touch with their skin.

The wearer's chest is covered by specific pads that are part of the wearable defibrillator. If a potentially fatal arrhythmia is found, these pads shock the heart therapeutically. 

People at risk of sudden cardiac arrest (SCA) or life-threatening arrhythmias who have not yet received an implanted defibrillator or who are not eligible for one are frequently prescribed wearable defibrillators.

Usually worn beneath clothing, such as a vest, wearable defibrillators are made to be comfortable and unobtrusive. They offer a short-term solution for managing arrhythmias until the patient's condition stabilizes or a more permanent treatment option, like an ICD, is necessary.

It's crucial for anyone using a wearable defibrillator to get the right training on how to use it and to carefully adhere to the suggestions and instructions of their healthcare professional. Healthcare experts prescribe and oversee the use of wearable defibrillators to guarantee their effectiveness and safety.

GLOBAL WEARABLE DEFIBRILLATOR MARKET SIZE AND FORECAST

The Global wearable defibrillator market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

An announcement was made by Kestra Medical Technologies on the ASSURE Wearable Cardioverter Defibrillator (WCD) system. The ASSURE System is the newest form of therapy and monitoring for patients at risk of sudden cardiac arrest.

The ASSURE WCD system is the newest kind of therapy and monitoring available to save individuals at danger of sudden cardiac arrest. It contains a wearable gadget that can automatically identify cardiac arrhythmias and shock them if necessary.

The ASSURE WCD, ASSURE patient app, and Kestra CareStation remote patient data platform are all components of the whole Cardiac Recovery System, which together offer patients comfortable protection and clear information for healthcare professionals.

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many wearable defibrillators are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global wearable defibrillator and key vendor selection criteria
3. Where is the wearable defibrillator manufactured? What is the average margin per unit?
4. Market share of Global wearable defibrillator market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global wearable defibrillator in-house
6. key predictions for next 5 years in Global wearable defibrillator market
7. Average B-2-B wearable defibrillator market price in all segments
8. Latest trends in wearable defibrillator market, by every market segment
9. The market size (both volume and value) of the wearable defibrillator market in 2023-2030 and every year in between?
10. Production breakup of wearable defibrillator market, by suppliers and their OEM relationship